Physician

Nagarjuna R Ponugoti, M.D

According to 2025 Medicare claims, Nagarjuna Ponugoti, M.D (NPI: 1285601278) practices allergy/immunology in the Terre Haute, IN market, with the plurality of this provider's patient population coming from Vigo, IN. This provider's primary affiliated billing organization is ALLERGY ASTHMA AND IMMUNOLOGY ASSOCIATES OF TH LLC (NPI: 1295934065; TIN: 352080161) and primary practice location at 47802-4559.

Ponugoti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 139 traditional Medicare patients, billed 9,265 HCPCS/CPT codes, and received $188,087 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 879 prescription claims across 153 beneficiaries totaling $444,564 in drug costs, led by Nucala (Mepolizumab). DME data shows 133 claims. Open Payments data shows 9 records totaling $155. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $93,105 to $444,564. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	153	6,751	$108,251
2016	165	9,287	$153,848
2017	171	11,072	$196,339
2018	180	11,296	$217,046
2019	228	12,930	$227,157
2020	193	13,574	$286,151
2021	174	11,882	$261,912
2022	151	8,946	$187,079
2023	141	9,105	$187,674
2024	139	9,265	$188,087

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	107	652	$93,105
2016	119	748	$104,498
2017	123	813	$191,044
2018	131	757	$264,296
2019	142	841	$317,281
2020	146	876	$247,452
2021	142	826	$309,644
2022	144	754	$202,670
2023	145	759	$238,900
2024	153	879	$444,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	50	$832
2016	N/R	N/R	N/R
2017	N/R	90	$53,603
2018	N/R	275	$231,504
2019	N/R	211	$235,354
2020	N/R	171	$239,570
2021	N/R	158	$238,351
2022	N/R	176	$276,896
2023	N/R	124	$192,261
2024	N/R	133	$184,062

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	53	123	$57
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	79	153	$36
94010	Test to measure expiratory airflow and volume	40	47	$18
95024	Test for allergy using allergenic extract injected into skin	32	815	$5
95004	Test for allergy using allergenic extract	32	1,696	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nucala	Mepolizumab	32	896	$120,576
Xolair	Omalizumab	34	952	$100,980
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	77	3,600	$75,156
Dupixent Pen	Dupilumab	16	434	$64,309
Breo Ellipta	Fluticasone/Vilanterol	26	1,080	$14,377

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	25	$104,663
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$53,169
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	11	$23,174
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	38	$2,567
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	46	$489

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$155	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nagarjuna R. Ponugoti, M.D?

Tedicare shows public-source Medicare data for Nagarjuna R. Ponugoti, M.D (NPI 1285601278), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nagarjuna R. Ponugoti, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nagarjuna R. Ponugoti, M.D?

Nagarjuna R. Ponugoti, M.D is linked to ALLERGY ASTHMA AND IMMUNOLOGY ASSOCIATES OF TH LLC (billing NPI 1295934065) in the available physician profile data.

Does Nagarjuna R. Ponugoti, M.D have Open Payments data?

Nagarjuna R. Ponugoti, M.D has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.